(4S,5R)-4,5-DIPHENYL-2-(PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

Chapa de níquel 99,98% 3 x 100 x 100 mm 1 ud.

Diethyl (4-(5-oxido-10H-phenothiazin-10-yl)butyl)phosphonate, 97%, 250mg

1-Bromo-2,4-difluoro-5-methoxybenzene, 98%, 1g

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 1g

NBD-CO-Hz [=4-(N-Hydrazinocarbonylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole] [for HPLC Labeling]>95.0%(HPLC)100mg

Guantes de protección química Butoject® 897, Talla, 8, 1 Par

4-(1H-Pyrazol-1-yl)benzoic acid, 95.0%, 10g

2-((7-(3,4-Dimethoxyphenyl)quinoxalin-2-yl)amino)-N-methylacetamide, 98%, 10mg

1-(3-Chloropropyl)piperidine hydrochloride, 97.0%, 5g

Tetrahidrofurano, mínimo 99,5 %, para síntesis, 250 ml, envase de vidrio

6,8-Dibromo-2-methyl-[1,2,4]triazolo[1,5-a]pyrazine, 95+%, 250mg

(R)-2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-dicarboxaldehyde, 97%, 1g